A portion of amino acids 428-457 from human AKT1 was used as the immunogen for this AKT antibody.
In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. [RefSeq].
